A method for treating autoimmune and/or inflammatory disease includes a step of identifying a subject exhibiting symptoms of autoimmune and/or inflammatory disease administering a fasting mimicking diet. A probiotic composition for gastrointestinal autoimmune and/or inflammatory disease Bacteroides acidifaciens, Bifidobacterium choerinum, and combinations thereof is also provided.

The invention relates to a multilayer reconstituted plant sheet suitable for devices which heat tobacco without burning it, said reconstituted plant sheet having a high density.

The invention relates to a multilayer reconstituted plant sheet suitable for devices which heat tobacco without burning it, said reconstituted plant sheet having a high density.

A system and method for a salve, spray, and tincture that help with rheumatism, arthritis, gout, and any other inflammation in joints or muscles whereby decarboxylation helps activate the herbs to help with how fast the relief works, while being infused in coconut oil, whereby the spray has wheatgerm oil for pain and safflower oil and eves primrose oil helps dissolve lactic and uric acid build up in joints that cause arthritis and the tincture whereby the tincture is created from the remaining herbs in the creation of the salve and sat in Everclear.

A system and method for a salve, spray, and tincture that help with rheumatism, arthritis, gout, and any other inflammation in joints or muscles whereby decarboxylation helps activate the herbs to help with how fast the relief works, while being infused in coconut oil, whereby the spray has wheatgerm oil for pain and safflower oil and eves primrose oil helps dissolve lactic and uric acid build up in joints that cause arthritis and the tincture whereby the tincture is created from the remaining herbs in the creation of the salve and sat in Everclear.

A method for treating or suppressing inflammatory disease includes administering a composition to a subject in need thereof. The composition includes a composite extract of beet, red onion, and purple sweet potato as an active ingredient. The composition has no cytotoxicity, effectively inhibits NO-mediated inflammatory reactions, inhibits the production of IL-6 protein, and inhibits the expression of iNOS COX-2 genes, which are representative inflammation-related genes, thus having an excellent anti-inflammatory effect, and so it can be usefully used for the treatment and prevention of inflammatory diseases in cosmetics, food, and quasi-drug fields. In addition, the composition of the present invention is not only very safe to human body but also excellent in stability.

A method for treating or suppressing inflammatory disease includes administering a composition to a subject in need thereof. The composition includes a composite extract of beet, red onion, and purple sweet potato as an active ingredient. The composition has no cytotoxicity, effectively inhibits NO-mediated inflammatory reactions, inhibits the production of IL-6 protein, and inhibits the expression of iNOS COX-2 genes, which are representative inflammation-related genes, thus having an excellent anti-inflammatory effect, and so it can be usefully used for the treatment and prevention of inflammatory diseases in cosmetics, food, and quasi-drug fields. In addition, the composition of the present invention is not only very safe to human body but also excellent in stability.

The present invention relates to a pharmaceutical composition for use in the treatment of prostate pathologies. The present invention further relates to a composition comprising a mixture which comprises or, alternatively, consists of an effective amount of Serenoa repens, Bromelain, Curcumin, Zinc, Lycopene and Selenium, and pharmaceutically acceptable or food grade technological excipients and/or additives. The present invention further relates to a pharmaceutical composition, preferably in the form of softgel capsules, for use in the treatment of disorders or diseases or pathologies connected to and/or deriving from prostatitis and/or benign prostatic hyperplasia.

The present invention relates to a pharmaceutical composition for use in the treatment of prostate pathologies. The present invention further relates to a composition comprising a mixture which comprises or, alternatively, consists of an effective amount of Serenoa repens, Bromelain, Curcumin, Zinc, Lycopene and Selenium, and pharmaceutically acceptable or food grade technological excipients and/or additives. The present invention further relates to a pharmaceutical composition, preferably in the form of softgel capsules, for use in the treatment of disorders or diseases or pathologies connected to and/or deriving from prostatitis and/or benign prostatic hyperplasia.

A composition includes a cannabinoid agent in a range of 0.005% to 1%, a terpene agent in a range of 0.005% to 1%, and a co-fermented herbal complex in a range of 5% to 40%. The cannabinoid agent can include CBD, CBN, CBG, or a combination thereof. The composition can further include ashwagandha.